搜尋結果
2024年04月11日 第40回吉岡彌生記念講演会のご案内：2024年5月22日～29日配信 2024年02月21日 好評受付中！ 3月7日（木）第10回地域連携セミナー 2024年02月02日 【プレスリリース】男子看護学生のためのキャリアセミナー開催のお知らせ 2023年12月07日 【1/18(木)開催】高橋倫子先生ご登壇！
Tokyo Women’ s Medical University originated from Tokyo Women’ s Medical School, which was commenced in 1900. YOSHIOKA Yayoi, the founder of Tokyo Women’ s Medical University, adopted the concept of the primary mission of Tokyo Women’ s Medical School as the founding spirit when she newly established Tokyo Women’ s Medical College ...
The international student exchange program at Tokyo Women's Medical University (TWMU) was initiated through a partnership agreement with Cardiff University (UK) in 1997. TWMU became the first among the private medical universities in Japan to encourage and accredit study abroad programs. Since then, TWMU School of Medicine has partnered with 12 ...
In order to nurture medical professionals who can promote research in medical sciences and make further benecial contributions to medical sciences and society, we have established the Graduate School of Medical Science (usually a 4-year doctoral course and a 3-year course for exceptional cases).The Ph.D. degree is given to students who have ...
Tokyo Women’s Medical University has developed from Tokyo Women’s Medical School and has produced many female physicians who have contributed to our society. Tokyo Women’s Medical University School of Medicine was established in 1950. Tokyo Women’s Medical College was established in 1952.Then, in 1998, the School of Nursing was added.
index_english. TWMU is a medical university with over one hundred years of history which now has a modern and sophisticated educational, clinical and research environments. Traditionally all of our undergraduate schools are devoted to develop women’s professionalism.
概要. 生体臓器の機能が低下、もしくは廃絶した患者に対し、臓器移植、あるいは人工心臓、透析機といった代用臓器が臨床の現場で広く利用されています。 さらには再生医療の進歩により、細胞から組織・臓器を作る研究開発も加速しています。 代用臓器学分野では、最先端科学を駆使した新しい代用臓器の研究・開発に主眼をおいています。 代用臓器学分野においては「バイオマテリアル」がそれを支える基本要素であり、生体・組織適合性材料をはじめ、すべての医用材料を対象としています。 また次世代再生医療として臓器創世に向けた取り組みも始まっており、細胞の大量培養、血管網付与によるスケールアップ、バイオリアクターを用いた組織・臓器培養、また、それらに関する装置作製などの技術開発を対象とします。 研究可能テーマ.
